Defining the optimal activated clotting time during percutaneous coronary intervention: Aggregate results from 6 randomized, controlled trials Review uri icon

Overview

MeSH Major

  • Angioplasty, Balloon, Coronary
  • Heparin
  • Randomized Controlled Trials as Topic
  • Thrombosis
  • Whole Blood Coagulation Time

abstract

  • Contrary to recent reports, the optimal suppression of ischemic events with unfractionated heparin therapy in patients undergoing percutaneous coronary intervention demands treatment to ACT levels that are substantially higher than currently appreciated. These data define a goal for heparin dosing within coronary interventions and establish a benchmark of optimal unfractionated heparin therapy against which future trials of novel antithrombotic regimens in percutaneous interventions can be compared.

publication date

  • February 20, 2001

Research

keywords

  • Review

Identity

Language

  • eng

PubMed ID

  • 11181470

Additional Document Info

start page

  • 961

end page

  • 6

volume

  • 103

number

  • 7